Statin and BMP

Ohnaka Keizo, Ryoichi Takayanagi

Research output: Contribution to journalReview article

Abstract

Bone morphogenetic proteins (BMP) are cytokines that promote differentiation of mesenchymal stem cells into differentiated osteoblasts and bone formation. Recently, HMG-CoA reductase inhibitors (statins) emerged as a candidate for the treatment of osteoporosis, because they stimulate BMP-2 expression and bone formation. Inhibition of Rho/Rho-kinase pathway may be involved in statin effect on bone formation.

Original languageEnglish
Pages (from-to)286-288
Number of pages3
JournalClinical calcium
Volume14
Issue number2
Publication statusPublished - Jan 1 2004

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Keizo, O., & Takayanagi, R. (2004). Statin and BMP. Clinical calcium, 14(2), 286-288.